Learn More
Medchemexpress LLC C14H11NO2S | 36341-25-0 | 99.3% | 257.31 | 50 MG

Supplier: Medchemexpress LLC HY1861950MG
YL-109 is an antitumor agent that can induce carboxyl terminus of Hsp70-interacting protein (CHIP) expression through aryl hydrocarbon receptor (AhR) signaling. It has the ability to inhibit breast cancer cell growth and invasiveness.
- Inhibits cell proliferation, motility, and invasiveness in breast cancer cells.
- Increases both CHIP mRNA and protein levels in MDA-MB-231 cells.
- Inhibits tumor growth and cancer metastasis of breast cancer cells in vivo.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.